References
- Bio LL, Kruger JF, Lee BP, Wood MS, Schwenk HT. Predictors of
Antimicrobial Stewardship Program Recommendation Disagreement. Infect
Control Hosp Epidemiol 2018;39(7):806–813.
- Abbo LM, Ariza-Heredia EJ. Antimicrobial Stewardship in
Immunocompromised Hosts. Infect Dis Clin North Am 2014;28(2):263–279.
- Lehrnbecher T, Phillips R, Alexander S, Alvaro F, Carlesse F, Fisher
B, Hakim H, Santolaya M, Castagnola E, Davis BL, Dupuis LL, Gibson F,
Groll AH, Gaur A, Gupta A, Kebudi R, Petrilli S, Steinbach WJ,
Villarroel M, Zaoutis T, Sung L, International Pediatric Fever and
Neutropenia Guideline Panel. Guideline for the management of fever and
neutropenia in children with cancer and/or undergoing hematopoietic
stem-cell transplantation. J Clin Oncol 2012;30(35):4427–4438.
- Schmidt-Hieber M, Teschner D, Maschmeyer G, Schalk E. Management of
febrile neutropenia in the perspective of antimicrobial de-escalation
and discontinuation. Expert Rev Anti Infect Ther 2019;17(12):983–995.
- Gyssens IC, Kern WV, Livermore DM, ECIL-4, a joint venture of EBMT,
EORTC, ICHS and ESGICH of ESCMID. The role of antibiotic stewardship
in limiting antibacterial resistance among hematology patients.
Haematologica 2013;98(12):1821–1825.
- Dommett R, Geary J, Freeman S, Hartley J, Sharland M, Davidson A,
Tulloh R, Taj M, Stoneham S, Chisholm JC. Successful introduction and
audit of a step-down oral antibiotic strategy for low risk paediatric
febrile neutropaenia in a UK, multicentre, shared care setting. Eur J
Cancer 2009;45(16):2843–2849.
- Paskovaty A, Pastores SM, Gedrimaite Z, Kostelecky N, Riedel ER, Seo
SK. Antimicrobial de-escalation in septic cancer patients: is it safe
to back down? Intensive Care Med 2015;41(11):2022–2023.
- Gustinetti G, Raiola AM, Varaldo R, Galaverna F, Gualandi F, Del Bono
V, Bacigalupo A, Angelucci E, Viscoli C, Mikulska M. De-Escalation and
Discontinuation of Empirical Antibiotic Treatment in a Cohort of
Allogeneic Hematopoietic Stem Cell Transplantation Recipients during
the Pre-Engraftment Period. Biol Blood Marrow Transplant 2018;24(8):
1721–1726.
- Scheler M, Lehrnbecher T, Groll AH, Volland R, Laws H-J, Ammann RA,
Agyeman P, Attarbaschi A, Lux M, Simon A. Management of children with
fever and neutropenia: results of a survey in 51 pediatric cancer
centers in Germany, Austria, and Switzerland. Infection
2020;48(4):607–618.
- Pillinger KE, Bouchard J, Withers ST, Mediwala K, McGee EU, Gibson GM,
Bland CM, Bookstaver PB. Inpatient Antibiotic Stewardship
Interventions in the Adult Oncology and Hematopoietic Stem Cell
Transplant Population: A Review of the Literature. Ann Pharmacother
2020;54(6):594–610.
- Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos
C, Falantes J, Vázquez-López L, Montero MI, Rosso-Fernández C, de la
Luz Martino M, Parody R, González-Campos J, Garzón-López S,
Calderón-Cabrera C, Barba P, Rodríguez N, Rovira M, Montero-Mateos E,
Carratalá J, Pérez-Simón JA, Cisneros JM. Optimisation of empirical
antimicrobial therapy in patients with haematological malignancies and
febrile neutropenia (How Long study): an open-label, randomised,
controlled phase 4 trial. Lancet Haematol 2017;4(12):e573–e583.
- Karagiannidou S, Triantafyllou C, Zaoutis TE, Papaevangelou V,
Maniadakis N, Kourlaba G. Length of stay, cost, and mortality of
healthcare-acquired bloodstream infections in children and neonates: A
systematic review and meta-analysis. Infect Control Hosp Epidemiol
2020;41(3):342–354.
- Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA,
Beauchemin M, Carlesse F, Groll AH, Haeusler GM, Santolaya M,
Steinbach WJ, Castagnola E, Davis BL, Dupuis LL, Gaur AH, Tissing WJE,
Zaoutis T, Phillips R, Sung L. Guideline for the Management of Fever
and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell
Transplantation Recipients: 2017 Update. J Clin Oncol
2017;35(18):2082–2094.
- Vicente M, Al-Nahedh M, Parsad S, Knoebel RW, Pisano J, Pettit NN.
Impact of a clinical pathway on appropriate empiric vancomycin use in
cancer patients with febrile neutropenia. J Oncol Pharm Pract
2017;23(8):575–581.
- Wattier RL, Levy ER, Sabnis AJ, Dvorak CC, Auerbach AD. Reducing
Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and
Hematopoietic Stem Cell Transplantation Services. Infect Control Hosp
Epidemiol 2017;38(9):1039–1047.
- Tomiak AT, Yau JC, Huan SD, Cripps MC, Goel R, Perrault DJ, Bourcier
JD, Prosser IA, Soltys KM, Evans WK, Stewart DJ. Duration of
intravenous antibiotics for patients with neutropenic fever. Ann Oncol
1994;5(5):441–445.
- Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad
II, Rolston KV, Young J-AH, Wingard JR, Infectious Diseases Society of
America. Clinical practice guideline for the use of antimicrobial
agents in neutropenic patients with cancer: 2010 update by the
Infectious Diseases Society of America. Clin Infect Dis
2011;52(4):e56-93.
- Morris AM. Antimicrobial Stewardship Programs: Appropriate Measures
and Metrics to Study their Impact. Curr Treat Options Infect Dis
2014;6(2):101–112.
- Dalton BR, MacTavish SJ, Bresee LC, Rajapakse N, Vanderkooi O,
Vayalumkal J, Conly J. Antimicrobial Use Over a Four-Year Period Using
Days of Therapy Measurement at a Canadian Pediatric Acute Care
Hospital. Can J Infect Dis Med Microbiol 2015;26(5):253–258.
- Feretzakis G, Loupelis E, Sakagianni A, Skarmoutsou N, Michelidou S,
Velentza A, Martsoukou M, Valakis K, Petropoulou S, Koutalas E. A
2-Year Single-Centre Audit on Antibiotic Resistance of Pseudomonas
aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae Strains
from an Intensive Care Unit and Other Wards in a General Public
Hospital in Greece. Antibiotics 2019;8(2):62.
- Maraki S, Mantadakis E, Nioti E, Samonis G. Susceptibility of 2,252Pseudomonas aeruginosa Clinical Isolates Over 4 Years to 9
Antimicrobials in a Tertiary Greek Hospital. Chemotherapy
2014;60(5-6):334–341.
- Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP,
Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ,
Billeter M, Hooton TM. Infectious Diseases Society of America and the
Society for Healthcare Epidemiology of America Guidelines for
Developing an Institutional Program to Enhance Antimicrobial
Stewardship. Clin Infect Dis 2007;44(2):159–177.
- Baugh CW, Wang TJ, Caterino JM, Baker ON, Brooks GA, Reust AC, Pallin
DJ. Emergency Department Management of Patients With Febrile
Neutropenia: Guideline Concordant or Overly Aggressive? Acad Emerg Med
2017;24(1):83–91.
- Boggan JC, Navar-Boggan AM, Jhaveri R. Pediatric-specific
antimicrobial susceptibility data and empiric antibiotic selection.
Pediatrics 2012;130(3):e615–622.
- Mantadakis E, Tsalkidis A, Panopoulou M, Pagkalis S, Tripsianis G,
Falagas ME, Kartali-Ktenidou S, Chatzimichael A. Antimicrobial
susceptibility of pediatric uropathogens in Thrace, Greece. Int Urol
Nephrol 2011;43(2):549–555.
- Styczynski J, Czyzewski K, Wysocki M, Gryniewicz-Kwiatkowska O,
Kolodziejczyk-Gietka A, Salamonowicz M, Hutnik L, Zajac-Spychala O,
Zaucha-Prazmo A, Chelmecka-Wiktorczyk L, Siewiera K, Fraczkiewicz J,
Malas Z, Tomaszewska R, Irga-Jaworska N, Plonowski M, Ociepa T,
Pierlejewski F, Gamrot Z, Urbanek-Dadela A, Gozdzik J, Stolpa W,
Dembowska-Baginska B, Perek D, Matysiak M, Wachowiak J, Kowalczyk J,
Balwierz W, Kalwak K, Chybicka A, Badowska W, Szczepanski T, Drozynska
E, Krawczuk-Rybak M, Urasinski T, Mlynarski W, Woszczyk M, Karolczyk
G, Sobol-Milejska G, Gil L. Increased risk of infections and
infection-related mortality in children undergoing haematopoietic stem
cell transplantation compared to conventional anticancer therapy: a
multicentre nationwide study. Clin Micrbiol Infect
2016;22(2):179.e1-179.e10.
- Robinson PD, Lehrnbecher T, Phillips R, Dupuis LL, Sung L. Strategies
for Empiric Management of Pediatric Fever and Neutropenia in Patients
With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A
Systematic Review of Randomized Trials. J Clin Oncol
2016;34(17):2054–2060.
- Groll AH, Castagnola E, Cesaro S, Dalle J-H, Engelhard D, Hope W,
Roilides E, Styczynski J, Warris A, Lehrnbecher T. Fourth European
Conference on Infections in Leukaemia (ECIL-4): guidelines for
diagnosis, prevention, and treatment of invasive fungal diseases in
paediatric patients with cancer or allogeneic haemopoietic stem-cell
transplantation. Lancet Oncol 2014;15(8):e327–340.
- 2020 exceptional surveillance of neutropenic sepsis: prevention and
management in people with cancer (NICE guideline CG151). London,
National Institute for Health and Care Excellence (UK); 2020.
- Alexander SW, Wade KC, Hibberd PL, Parsons SK. Evaluation of risk
prediction criteria for episodes of febrile neutropenia in children
with cancer. J Pediatr Hematol Oncol 2002;24(1):38–42.
- Castagnola E, Caviglia I, Pistorio A, Fioredda F, Micalizzi C, Viscoli
C, Haupt R. Bloodstream infections and invasive mycoses in children
undergoing acute leukaemia treatment: A 13-year experience at a single
Italian institution. Eur J Cancer 2005;41(10):1439–1445.
- Fisher BT, Robinson PD, Lehrnbecher T, Steinbach WJ, Zaoutis TE,
Phillips B, Sung L. Risk Factors for Invasive Fungal Disease in
Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A
Systematic Review. J Pediatric Infect Dis Soc 2018;7(3):191–198.
- Caselli D, Cesaro S, Ziino O, Ragusa P, Pontillo A, Pegoraro A,
Santoro N, Zanazzo G, Poggi V, Giacchino M, Livadiotti S, Melchionda
F, Chiodi M, Aricò M. A prospective, randomized study of empirical
antifungal therapy for the treatment of chemotherapy-induced febrile
neutropenia in children. Br J Haematol 2012;158(2):249–255.